Proliferation and differentiation of osteoblast-like cells on apatite-wollastonite/polyethylene composites
Source abstract
Abstract
Glass-ceramic apatite-wollastonite (A-W)/high-density polyethylene composite (AWPEX) materials have been designed to match the mechanical strength of human cortical bone and to provide favourable bioactivity, with potential use in many orthopaedic applications. To better understand AWPEX properties, the effects of surface finish and ceramic filler size and content on osteoblast-like cell attachment, proliferation, and differentiation were examined. Glass-ceramic content was tested at 30 and 50 vol% and median particle size at 4.5 and 7.7 microm. Samples were prepared as 1 x 10 x 10 mm(3) tiles with polished or rough surfaces, sterilized by gamma irradiation (2.5 Mrad), and characterized by scanning electron microscopy (SEM) and surface profilometry. Saos-2 human osteoblast-like cells were cultured on each surface at an initial concentration of 4500 cells/cm(2) for 1, 3, or 7 days. At each time point, adenosine triphosphate and alkaline phosphatase levels were measured to assess cell number and osteoblast differentiation. SEM imaging of cells on the composite surfaces showed preferential cell attachment to filler particles within the polymer matrix. Significant biochemical assay differences were found at 7 days, confirmed by ANOVA post-hoc testing using Bonferroni's correction. Overall, increased exposure of the glass-ceramic A-W phase in AWPEX through surface polishing, higher volume fraction and/or larger particle size was found to lead to an improved cell response.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Orthopaedic implants and arthroplasty · Dental Implant Techniques and Outcomes
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (23)
Show source-provided references
1. Bonfield W, Bowman JA, Grynpas MD. Composite Material for use in Orthopaedics. UK Patent No. 2085461B, 1984.
2. Bonfield W, Bowman JA, Grynpas MD. Composite Material for use in Orthopaedics. US Patent No. 5017627, 1991.
3. Composites for bone replacement10.1016/0141-5425(88)90110-0 ↗
4. Apatite- and wollastonite-containing glass-ceramics for prosthetic applications
5. Bioactive glass ceramics10.1016/0142-9612(91)90194-F ↗
6. Bioactive glass ceramics10.1016/0142-9612(91)90194-F ↗
7. Apatite formation on three kinds of bioactive material at an early stage in vivo10.1002/jbm.820270805 ↗
8. AW glass-ceramic in spinal repair
9. A-W glass-ceramic reinforced polyethylene for medical applications
10. Apatite-forming ability of glass-ceramic A-W–polyethylene composites
11. Bonding strength of apatite layer formed on glass-ceramic A-W–polyethylene composites10.1002/jbm.a.10131 ↗
12. Expression of the osteoblast phenotype
13. Bone cell biology and the regulation of bone turnover
14. The human alkaline phosphatase, what we know and what we don’t know10.1016/0009-8981(90)90031-M ↗
15. Plasma specific alkaline phosphatase as an indicator of osteoblastic activity10.1302/0301-620X.75B2.8444951 ↗
16. Specific activity of skeletal alkaline phosphatase in human osteoblast-like cells regulated by phosphate, phosphate esters, and phosphate analogs and release of alkaline phosphatase activity inversely regulated by calcium10.1002/jbmr.5650090409 ↗
17. The use of ATP Bioluminescence as a measure of cell proliferation and cytotoxicity10.1016/0022-1759(93)90011-U ↗
18. Processing, characterisation and evaluation of hydroxyapatite reinforced polyethylene composites
19. Effect of sand addition on the tensile properties of compression moulded sand/polyethylene composite system10.1016/S0167-577X(97)00154-7 ↗
20. Effect of polyethylene particles on human osteoblastic cell growth10.1016/S0142-9612(97)00250-0 ↗
21. Orthosilicic acid stimulates collagen type 1 synthesis and osteoblastic differentiation in human osteoblast-like cells in vitro10.1016/S8756-3282(02)00950-X ↗
22. Biochemical markers of bone metabolism in infants and children under intravenous corticosteroid therapy10.1007/s00223-002-2099-x ↗
23. Characterization of a human osteoblastic osteosarcoma cell line (Saos-2) with high bone alkaline phosphatase activity10.1002/jbmr.5650020310 ↗